Trial record 1 of 1 for:
INITIUM
UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04382664 |
|
Recruitment Status :
Completed
First Posted : May 11, 2020
Last Update Posted : April 18, 2024
|
Sponsor:
Ultimovacs ASA
Information provided by (Responsible Party):
Ultimovacs ASA
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | January 11, 2024 |
| Actual Study Completion Date : | April 10, 2024 |